Banyan Biomarkers, Inc.

Banyan Biomarkers, Inc. is creating the first blood test to diagnose traumatic brain injury (TBI). The company was founded in 2002 by scientists from the University of Florida McKnight Brain Institute with the vision to commercialize in vitro diagnostic tests for the detection of brain injury and neurological diseases. Banyan Biomarkers has made significant progress in developing and clinically validating novel enzyme linked immunosorbent assays (ELISAs) for traumatic brain injury.